• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[低剂量重组组织型纤溶酶原激活剂局部动脉内溶栓。腿部动脉闭塞性疾病的溶栓治疗]

[Local intra-arterial thrombolysis with low dosage rt-PA. Thrombolysis in arterial occlusive disease of the leg].

作者信息

Weidauer T, Timmermann J

机构信息

Radiologische Abteilung, Marienhospital in Altenessen, Akademisches Lehrkrankenhaus der Gesamthochschule Essen.

出版信息

Fortschr Med. 1990 Dec 20;108(36):700-2.

PMID:2128294
Abstract

In this study, 12 patients with arterial occlusions of the lower limb were treated with low-dose intra-arterial rt-PA. Although the group was heterogeneous (differences in length and duration of occlusion), good short-term and medium-term results were obtained. After local treatment with 2.5 mg/h rt-PA administered intra-arterially over 2.5 to 8 hours, most patients had no, or only mild, residual stenosis. Posttherapy, almost all patients were able to walk longer distances. Side effects were rare, and in only one case did treatment have to be discontinued because of pain in the treated limb.

摘要

在本研究中,12例下肢动脉闭塞患者接受了低剂量动脉内rt-PA治疗。尽管该组患者情况各异(闭塞长度和持续时间不同),但仍取得了良好的短期和中期效果。在以2.5毫克/小时的速率动脉内给予rt-PA进行2.5至8小时的局部治疗后,大多数患者没有或仅有轻度残余狭窄。治疗后,几乎所有患者都能行走更长的距离。副作用很少见,仅1例因治疗肢体疼痛而不得不停止治疗。

相似文献

1
[Local intra-arterial thrombolysis with low dosage rt-PA. Thrombolysis in arterial occlusive disease of the leg].[低剂量重组组织型纤溶酶原激活剂局部动脉内溶栓。腿部动脉闭塞性疾病的溶栓治疗]
Fortschr Med. 1990 Dec 20;108(36):700-2.
2
[Intra-arterial thrombolysis using rt-PA in peripheral arterial occlusions]].[使用重组组织型纤溶酶原激活剂(rt-PA)进行外周动脉闭塞的动脉内溶栓治疗]
Vasa Suppl. 1991;33:131.
3
[Selective thrombolysis of peripheral arterial occlusions using Rt-PA].[使用重组组织型纤溶酶原激活剂对周围动脉闭塞进行选择性溶栓]
Vasa Suppl. 1990;30:189-90.
4
[Effectiveness and tolerance of rt-Pa for local lytic therapy of 53 embolic and thrombotic occlusions of the lower extremity].rt-Pa用于53例下肢栓塞性和血栓性闭塞局部溶栓治疗的有效性和耐受性
Vasa Suppl. 1991;33:127.
5
[Local low dosage thrombolysis with rt-PA. Systemic effects on the fibrinolytic system--data on the assessment of the value and risk of this method].[rt-PA局部低剂量溶栓。对纤溶系统的全身影响——关于该方法价值和风险评估的数据]
Vasa Suppl. 1991;33:132-3.
6
[Local thrombolysis in peripheral arterial occlusion].[外周动脉闭塞的局部溶栓治疗]
Herz. 1989 Feb;14(1):12-21.
7
[Fibrinolysis with rt-PA in peripheral arterial occlusions].[重组组织型纤溶酶原激活剂在外周动脉闭塞症中的纤维蛋白溶解作用]
Klin Wochenschr. 1988;66 Suppl 12:135-6.
8
[Selective thrombolysis with recombinant tissue type plasminogen activator in combination with prostaglandin E1].[重组组织型纤溶酶原激活剂联合前列腺素E1进行选择性溶栓治疗]
Vasa Suppl. 1989;27:240.
9
Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.大剂量推注与小剂量组织纤溶酶原激活剂输注治疗急性肢体缺血的前瞻性随机试验。溶栓研究组。
Br J Surg. 1997 May;84(5):646-50.
10
[On-the-table lysis compared with overnight lysis in acute and subacute occlusions of peripheral arteries and bypasses].[外周动脉和旁路急性及亚急性闭塞时术中溶栓与夜间溶栓的比较]
Vasa Suppl. 1992;35:186.

引用本文的文献

1
Efficacy and tolerance of recombinant tissue-type plasminogen activator in patients with thrombotic or embolic occlusions of leg-arteries.
Clin Investig. 1993 Apr;71(4):323-6. doi: 10.1007/BF00184736.